Parenteral Nutrition Associated Liver Disease (PNALD) Clinical Trials in Chicago, Illinois

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment